Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Patent
1994-08-03
1995-11-07
Nucker, Christine M.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
424818, 435237, 435948, A61K 39215, C12N 708
Patent
active
054646219
ABSTRACT:
A live or inactivated canine corona virus vaccine is provided which is derived from a virus of the novel antigenic type of the canine corona virus strain I-743 (CNCM, Institut Pasteur, Paris). A method for the preparation of this vaccine and the use of said vaccine in protecting susceptible animals against canine corona virus injection are also disclosed.
REFERENCES:
patent: 4567042 (1986-01-01), Acree et al.
patent: 4567043 (1986-01-01), Acree et al.
patent: 4824785 (1989-04-01), Acree et al.
Appel M, "Canine Coronovirus" in Virus Infections of Carnivores, Appel M. J. ed, Chapter-11, Elsevier Science (Amsterdam) 1987, pp. 115-122.
Boslego et al, "Gonorrhea Vaccines" in Vaccines and Immunotherapy, Cryz S. J. ed, Chapter 17, Pergamon Press (New York), 1991 pp. 211-223.
Kallings et al "Placebo Controlled trial of two acellular pertussis Vaccines in Sweden-Protective efficacy and adverse events." Lancet I: 956-960, 1988.
Baxendale William
Chalmers William S. K.
Akzo N.V.
Blackstone William M.
Gormley Mary E.
Krsek-Staples Julie
Nucker Christine M.
LandOfFree
Canine corona virus vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Canine corona virus vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Canine corona virus vaccine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-195743